Global Facial Injectables Market Opportunities and Forecast 2023-2030

Facial Injectables Market Overview

The global facial injectables market is expected to grow at a very high rate during the forecast period. rising aesthetic consciousness and number of cosmetic procedures, and the aging population is boosting the growth of the global Facial Injectables market. Moreover, Factors such as increasing healthcare expenditure, growing investments in the dermatological and cosmetic surgery field, growing skincare techniques are driving the growth of the market

On the other hand, complication occurring during surgery and side effects associated with facial injectables is likely to hamper the global Facial Injectables market during the forecast period.

Covid-19 Impact on Facial Injectables Market:

In addition, the current Facial Injectables Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Facial Injectables market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Facial Injectables Market Segment Overview

On the basis of product, the CEE facial injectable market is segmented into dermal fillers/injectable implants and anti-aging/ anti-wrinkle injections. The dermal fillers segment is expected to dominate the CEE facial injectables market in 2020. The growth is projected mainly due to Hyaluronic acid, which is known for its ability to store moisture in the skin, thus making the skin look healthier. 

The end-user segment includes Multispecialty Clinics, dermatology clinics, beauty clinics, and dermatology research institutes. The Multispecialty Clinics segment is expected to hold the largest market share in 2020 as the number of Multispecialty Clinics and the flow of patients in hospital establishments is increasing at an exponential rate. However, the dermatology clinics segment is expected to witness the fastest growth during the forecast period.

Market Analysis, Insights and Forecast – By Product

·       Dermal Fillers/Injectable Implants
·       Anti-Aging/ Anti-Wrinkle Injections

Market Analysis, Insights, and Forecast – By End User

·       Multispecialty Clinics
·       Dermatology Clinics
·       Beauty Clinics
·       Dermatology Research Institutes

Facial Injectables Market Regional Overview

Region-wise, North America dominated the global Facial Injectables market owing to the rapid growth rate in the use of Botox injections. As per the American Society of Plastic Surgeons (ASPS), the use of Botox injections increased by 845% by comparing the rates of cosmetic surgery products from the year 2000 to 2018

The Asia Pacific is also expected to account for the fastest growth in the global market owing to well-established health care infrastructure. Factors such as growing self-awareness for perfect physical appearances among millennials in the countries such as China, Japan, and South Korea are expected to escalate the growth of the Facial Injectables market in the Asia Pacific region.

Facial Injectables Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Facial Injectables Market Competitor overview

Some key developments and strategies adopted by manufacturers in the Facial Injectables are highlighted below.

·       In October 2019, U.S. Food and Drug Administration (FDA) approved Allergan’s supplemental Biologics License Application (sBLA) for BOTOX for the treatment of pediatric patients (2 to 17 years of age) with lower limb spasticity, excluding spasticity caused by cerebral palsy (CP). 

Facial Injectables Market, Key Players

·       Medytox Inc.
·       ALLERGAN
·       Ipsen SA
·       Sanofi SA
·       Merz Pharma
·       Anika Therapeutics, Inc.
·       Galderma S.A.
·       Suneva Medical, Inc.
·       Sinclair Pharma PLC
·       Teoxane SA